JP2013518050A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013518050A5 JP2013518050A5 JP2012550137A JP2012550137A JP2013518050A5 JP 2013518050 A5 JP2013518050 A5 JP 2013518050A5 JP 2012550137 A JP2012550137 A JP 2012550137A JP 2012550137 A JP2012550137 A JP 2012550137A JP 2013518050 A5 JP2013518050 A5 JP 2013518050A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- heteroaryl
- aryl
- ring
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33646010P | 2010-01-22 | 2010-01-22 | |
| US61/336,460 | 2010-01-22 | ||
| PCT/US2011/021982 WO2011091213A2 (en) | 2010-01-22 | 2011-01-21 | Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016100346A Division JP2016153425A (ja) | 2010-01-22 | 2016-05-19 | タンパク質デアセチラーゼ阻害剤としてのリバースアミド化合物とその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013518050A JP2013518050A (ja) | 2013-05-20 |
| JP2013518050A5 true JP2013518050A5 (enExample) | 2016-05-12 |
| JP5940984B2 JP5940984B2 (ja) | 2016-06-29 |
Family
ID=44307593
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012550137A Expired - Fee Related JP5940984B2 (ja) | 2010-01-22 | 2011-01-21 | タンパク質デアセチラーゼ阻害剤としてのリバースアミド化合物とその使用方法 |
| JP2016100346A Pending JP2016153425A (ja) | 2010-01-22 | 2016-05-19 | タンパク質デアセチラーゼ阻害剤としてのリバースアミド化合物とその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016100346A Pending JP2016153425A (ja) | 2010-01-22 | 2016-05-19 | タンパク質デアセチラーゼ阻害剤としてのリバースアミド化合物とその使用方法 |
Country Status (28)
| Country | Link |
|---|---|
| US (7) | US8394810B2 (enExample) |
| EP (2) | EP3091004B1 (enExample) |
| JP (2) | JP5940984B2 (enExample) |
| KR (1) | KR101808874B1 (enExample) |
| CN (3) | CN105753739A (enExample) |
| AU (1) | AU2016213729A1 (enExample) |
| BR (1) | BR112012018246B1 (enExample) |
| CA (1) | CA2787756C (enExample) |
| CL (1) | CL2012002026A1 (enExample) |
| CY (1) | CY1118156T1 (enExample) |
| DK (1) | DK2526093T3 (enExample) |
| EA (1) | EA026514B1 (enExample) |
| ES (1) | ES2592278T3 (enExample) |
| HR (1) | HRP20161367T1 (enExample) |
| HU (1) | HUE030679T2 (enExample) |
| LT (1) | LT2526093T (enExample) |
| MX (1) | MX2012008553A (enExample) |
| NZ (1) | NZ601655A (enExample) |
| PH (1) | PH12012501492B1 (enExample) |
| PL (1) | PL2526093T3 (enExample) |
| PT (1) | PT2526093T (enExample) |
| RS (1) | RS55227B1 (enExample) |
| SG (2) | SG10201500444TA (enExample) |
| SI (1) | SI2526093T1 (enExample) |
| SM (1) | SMT201600382B (enExample) |
| TW (3) | TWI511732B (enExample) |
| WO (1) | WO2011091213A2 (enExample) |
| ZA (1) | ZA201206063B (enExample) |
Families Citing this family (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ601655A (en) * | 2010-01-22 | 2014-10-31 | Acetylon Pharmaceuticals Inc | Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof |
| WO2012018499A2 (en) * | 2010-08-05 | 2012-02-09 | Acetylon Pharmaceuticals | Specific regulation of cytokine levels by hdac6 inhibitors |
| ES2647368T3 (es) | 2010-10-08 | 2017-12-21 | Vib Vzw | Inhibidores de HDAC para tratar la enfermedad de Charcot-Marie-Tooth |
| PL2640709T3 (pl) | 2010-11-16 | 2016-10-31 | Związki pirymidynohydroksyamidowe jako inhibitory deacetylazy białkowej oraz sposoby ich stosowania” | |
| WO2012117421A1 (en) | 2011-03-02 | 2012-09-07 | Orchid Research Laboratories Ltd | Histone deacetylase inhibitors |
| FR2975911A1 (fr) * | 2011-06-06 | 2012-12-07 | Univ Strasbourg | Bisacodyl et analogues comme medicaments destines au traitement du cancer |
| JP6169076B2 (ja) * | 2011-07-20 | 2017-07-26 | ザ ジェネラル ホスピタル コーポレイション | 骨疾患の処置のためのヒストン脱アセチル化酵素６選択的阻害剤 |
| KR101359571B1 (ko) | 2011-10-06 | 2014-02-10 | 서울대학교산학협력단 | Ｈｄａｃ 저해제와 알파칼슘설페이트를 유효성분으로 함유하는 치주질환 예방 및 치료용 약학적 조성물 |
| AU2013234955A1 (en) | 2012-03-23 | 2014-11-13 | Dennis Brown | Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo |
| EP2839037B1 (en) * | 2012-04-19 | 2018-12-26 | Acetylon Pharmaceuticals, Inc. | Biomarkers to identify patients that will respond to treatment and treating such patients |
| US9145412B2 (en) | 2012-11-02 | 2015-09-29 | Acetylon Pharmaceuticals, Inc. | Selective HDAC1 and HDAC2 inhibitors |
| WO2015054099A1 (en) * | 2013-10-08 | 2015-04-16 | Acetylon Pharmaceuticals, Inc. | Combinations of histone deacetylase inhibitors and either her2 inhibitors or pi3k inhibitors |
| JP2016536354A (ja) * | 2013-10-10 | 2016-11-24 | アセチロン ファーマシューティカルズ インコーポレイテッドＡｃｅｔｙｌｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | 非ホジキンリンパ腫を治療するための、ｈｄａｃ阻害剤単独またはｂｔｋ阻害剤との組み合わせ |
| US20150105383A1 (en) * | 2013-10-10 | 2015-04-16 | Acetylon Pharmaceuticals, Inc. | HDAC Inhibitors, Alone Or In Combination With PI3K Inhibitors, For Treating Non-Hodgkin's Lymphoma |
| ES2862126T3 (es) | 2013-10-10 | 2021-10-07 | Acetylon Pharmaceuticals Inc | Compuestos de pirimidín-hidroxiamida como inhibidores de histona desacetilasa |
| KR20160060143A (ko) * | 2013-10-11 | 2016-05-27 | 에이스틸론 파마수티컬스 인코포레이티드 | 히스톤 디아세틸라아제 억제제와 면역조절성 약물의 조합물 |
| US10660890B2 (en) | 2013-10-24 | 2020-05-26 | National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government Nih Division Of Extramural Inventions And Technology Resources (Deitr) | Treatment of polycystic diseases with an HDAC6 inhibitor |
| ES2806258T3 (es) * | 2013-12-03 | 2021-02-17 | Acetylon Pharmaceuticals Inc | Combinaciones de inhibidores de histona desacetilasa y fármacos inmunomoduladores |
| US9464073B2 (en) | 2014-02-26 | 2016-10-11 | Acetylon Pharmaceuticals, Inc. | Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors |
| MX2016011833A (es) | 2014-03-12 | 2017-03-29 | Chong Kun Dang Pharmaceutical Corp | Nuevos compuestos como inhibidores de histona desacetilasa 6 y composiciones farmaceuticas que los comprenden. |
| TW201625620A (zh) * | 2014-05-14 | 2016-07-16 | 美國科羅拉多州立大學 | 作為蛋白去乙醯酶抑制劑及雙蛋白去乙醯酶蛋白激酶抑制劑之雜環氧肟酸及其使用方法 |
| SG11201700094TA (en) * | 2014-07-07 | 2017-02-27 | Acetylon Pharmaceuticals Inc | Treatment of leukemia with histone deacetylase inhibitors |
| US9937174B2 (en) | 2014-12-05 | 2018-04-10 | University of Modena and Reggio Emilia | Combinations of histone deacetylase inhibitors and bendamustine |
| BR112017012504A2 (pt) | 2014-12-12 | 2018-01-09 | Acetylon Pharmaceuticals, Inc. | derivados de piperidina como inibidores de hdac1/2 |
| WO2016126726A1 (en) | 2015-02-02 | 2016-08-11 | Forma Therapeutics, Inc. | Bicyclic [4,6,0] hydroxamic acids as hdac6 inhibitors |
| WO2016126721A1 (en) | 2015-02-02 | 2016-08-11 | Forma Therapeutics, Inc. | 3-aryl-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors |
| WO2016168647A1 (en) * | 2015-04-17 | 2016-10-20 | Acetylon Pharmaceuticals Inc. | Treatment of neuroblastoma with histone deacetylase inhibotrs |
| US10421778B2 (en) | 2015-05-05 | 2019-09-24 | Washington University | Isoform-selective lysine deacetylase inhibitors |
| CN108026057B (zh) | 2015-05-22 | 2021-08-06 | 株式会社钟根堂 | 用作选择性组蛋白脱乙酰酶抑制剂的杂环烷基衍生化合物及含其的药物组合物 |
| US10272084B2 (en) | 2015-06-01 | 2019-04-30 | Regenacy Pharmaceuticals, Llc | Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy |
| CN107922352B (zh) * | 2015-06-08 | 2021-08-06 | 埃斯泰隆制药公司 | 制备蛋白质脱乙酰酶抑制剂的方法 |
| TW201718516A (zh) | 2015-06-08 | 2017-06-01 | 艾斯特隆製藥公司 | 組蛋白去乙醯酶抑制劑之晶形 |
| CN105017135A (zh) * | 2015-07-19 | 2015-11-04 | 佛山市赛维斯医药科技有限公司 | 一类二吡啶叔醇结构的11β-HSD1抑制剂、制备方法及其用途 |
| CN104974084A (zh) * | 2015-07-19 | 2015-10-14 | 佛山市赛维斯医药科技有限公司 | 一类胺基二吡啶叔醇结构的11β-HSD1抑制剂及其用途 |
| CN104974080A (zh) * | 2015-07-19 | 2015-10-14 | 佛山市赛维斯医药科技有限公司 | 二吡啶叔醇结构的11β-HSD1抑制剂、制备方法及其用途 |
| NZ739211A (en) | 2015-07-27 | 2019-05-31 | Chong Kun Dang Pharmaceutical Corp | 1,3,4-oxadiazole amide derivative compound as histone deacetylase 6 inhibitor, and pharmaceutical composition containing same |
| PL3328843T3 (pl) | 2015-07-27 | 2023-02-27 | Chong Kun Dang Pharmaceutical Corp. | Związki będące pochodnymi 1,3,4 oksadiazolosulfonamidów jako inhibitor deacetylazy histonowej 6, oraz kompozycja farmaceutyczna je zawierająca |
| RU2695227C9 (ru) | 2015-07-27 | 2020-03-04 | Чонг Кун Данг Фармасьютикал Корп. | Производные 1,3,4-оксадиазолсульфамида в качестве ингибитора гистондеацетилазы 6 и содержащая их фармацевтическая композиция |
| US10154997B2 (en) | 2015-08-04 | 2018-12-18 | Washington University | Treatment of parasitic diseases using KDAC inhibitor compounds |
| PT3331864T (pt) | 2015-08-04 | 2022-01-18 | Chong Kun Dang Pharmaceutical Corp | Compostos derivados de 1,3,4-oxadiazol como inibidor de histona desacetilase 6 e a composição farmacêutica compreendendo os mesmos |
| US10040769B2 (en) * | 2015-10-27 | 2018-08-07 | Regenacy Pharmaceuticals, Llc | HDAC inhibitors for the treatment of diabetic peripheral neuropathy |
| WO2017142883A1 (en) * | 2016-02-16 | 2017-08-24 | The Board Of Trustees Of The University Of Illinois | Tetrahydroquinoline substituted hydroxamic acids as selective histone deacetylase 6 inhibitors |
| WO2017143237A1 (en) | 2016-02-17 | 2017-08-24 | Acetylon Pharmaceuticals, Inc. | Increasing expression of interferon regulated genes with combinatons of histone deacetylase inhibitors and immunomodulatory drugs |
| ES3057783T3 (en) | 2016-03-15 | 2026-03-04 | Oryzon Genomics Sa | Combinations of lsd1 inhibitors for use in the treatment of neoplastic diseases |
| US11013698B2 (en) | 2016-03-15 | 2021-05-25 | Oryzon Genomics S.A. | Combinations of LSD1 inhibitors for the treatment of hematological malignancies |
| US20170283445A1 (en) * | 2016-04-05 | 2017-10-05 | University Of South Carolina | Small Molecule Inhibitors Selective For Polo-Like Kinase Proteins |
| WO2017184774A1 (en) | 2016-04-19 | 2017-10-26 | Acetylon Pharmaceuticals, Inc. | Hdac inhibitors, alone or in combination with btk inhibitors, for treating chronic lymphocytic leukemia |
| US11298354B2 (en) * | 2016-06-09 | 2022-04-12 | Dana-Farber Cancer Institute, Inc. | Methods of use and pharmaceutical combinations of HDAC inhibitors with BET inhibitors |
| EP3472131B1 (en) | 2016-06-17 | 2020-02-19 | Forma Therapeutics, Inc. | 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors |
| ES2929032T3 (es) * | 2016-08-08 | 2022-11-24 | Acetylon Pharmaceuticals Inc | Combinaciones farmacéuticas de inhibidores de histona desacetilasa 6 y anticuerpos inhibidores de CD20 y usos de los mismos |
| US11998546B2 (en) | 2016-10-28 | 2024-06-04 | Acetylon Pharmaceuticals, Inc. | Pharmaceutical combinations comprising a histone deacetylase inhibitor and epothilone and methods of use thereof |
| JP7282674B2 (ja) | 2016-10-28 | 2023-05-29 | アセチロン ファーマシューティカルズ インコーポレイテッド | ヒストン脱アセチル化酵素阻害剤及びオーロラキナーゼ阻害剤を含む医薬品組み合わせならびにその使用方法 |
| ES2925197T3 (es) * | 2016-11-04 | 2022-10-14 | Acetylon Pharmaceuticals Inc | Combinaciones farmacéuticas que comprenden un inhibidor de histona desacetilasa y un inhibidor de BCL-2 y métodos de uso de las mismas |
| EP3544612A4 (en) | 2016-11-23 | 2020-05-13 | Acetylon Pharmaceuticals, Inc. | PHARMACEUTICAL COMBINATIONS COMPRISING A HISTONE DEACETYLASE INHIBITOR AND A CD38 INHIBITOR AND METHODS OF USING THE SAME |
| WO2018098168A1 (en) | 2016-11-23 | 2018-05-31 | Acetylon Pharmaceuticals, Inc. | Pharmaceutical combinations comprising a histone deacetylase inhibitor and a programmed death-ligand 1 (pd-l1) inhibitor and methods of use thereof |
| WO2019083960A1 (en) | 2017-10-24 | 2019-05-02 | Oncopep, Inc. | PEPTIDE VACCINES AND HDAC INHIBITORS FOR THE TREATMENT OF MULTIPLE MYELOMA |
| KR102236356B1 (ko) | 2017-11-24 | 2021-04-05 | 주식회사 종근당 | 루푸스의 예방 또는 치료를 위한 조성물 |
| WO2019106633A1 (en) | 2017-12-01 | 2019-06-06 | University of Modena and Reggio Emilia | Methods of use and pharmaceutical combinations comprising histone deacetylase inhibitors and jak 1 2 inhibitors |
| ES2718240A1 (es) | 2017-12-28 | 2019-06-28 | Univ Del Pais Vasco / Euskal Herriko Unibertsitatea | Desarrollo de nuevos inhibidores selectivos frente a hdac6 derivados del acido ursodecoxicolico |
| EP3737376B1 (en) * | 2018-01-09 | 2024-04-17 | Shuttle Pharmaceuticals, Inc. | Selective histone deacetylase inhibitors for the treatment of human diseases |
| KR20190099952A (ko) * | 2018-02-20 | 2019-08-28 | 주식회사 종근당 | 포도막염의 예방 또는 치료를 위한 조성물 |
| KR102316234B1 (ko) | 2018-07-26 | 2021-10-22 | 주식회사 종근당 | 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이를 포함하는 약제학적 조성물 |
| CN110885316B (zh) * | 2018-09-10 | 2023-03-28 | 上海中泽医药科技有限公司 | 作为组蛋白去乙酰化酶抑制剂的巯基化合物及其用途 |
| CN111943892B (zh) * | 2019-05-17 | 2022-04-05 | 上海中泽医药科技有限公司 | 组蛋白去乙酰化酶亚型抑制剂硫乙酰芳胺类化合物及用途 |
| MY207444A (en) | 2019-05-31 | 2025-02-27 | Chong Kun Dang Pharmaceutical Corp | 1,3,4-oxadiazole homophthalimide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same |
| FI3976604T3 (fi) | 2019-05-31 | 2026-04-08 | Chong Kun Dang Pharmaceutical Corp | 1,3,4-oksadiatsolijohdannaisyhdisteitä histonideasetylaasi 6:n estäjänä ja niitä käsittävä lääkekoostumus |
| KR102537615B1 (ko) | 2020-02-25 | 2023-05-30 | 주식회사 종근당 | 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이를 포함하는 약제학적 조성물 |
| KR102537616B1 (ko) | 2020-02-25 | 2023-05-26 | 주식회사 종근당 | 히스톤 탈아세틸화 효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이를 포함하는 약제학적 조성물 |
| KR102576148B1 (ko) | 2020-04-13 | 2023-09-07 | 주식회사 종근당 | 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이를 포함하는 약제학적 조성물 |
| WO2022013728A1 (en) | 2020-07-14 | 2022-01-20 | Chong Kun Dang Pharmaceutical Corp. | Novel compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same |
| JP2023539463A (ja) | 2020-08-17 | 2023-09-14 | アリゴス セラピューティクス インコーポレイテッド | Ｐｄ－ｌ１を標的とするための方法及び組成物 |
| KR102685058B1 (ko) | 2020-09-02 | 2024-07-15 | 주식회사 종근당 | 히스톤 탈아세틸화효소 6 억제제로서의 새로운 구조의 화합물 및 이를 포함하는 약제학적 조성물 |
| KR102905373B1 (ko) | 2021-04-08 | 2025-12-29 | 주식회사 종근당 | 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 싸이오카보닐 화합물 및 이를 포함하는 약제학적 조성물 |
| KR102904231B1 (ko) | 2022-04-07 | 2025-12-29 | 주식회사 종근당 | 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이의 용도 |
| CN114621754A (zh) * | 2022-04-18 | 2022-06-14 | 武汉轻工大学 | 一种荧光探针的制备及其在组蛋白去乙酰化酶中的应用 |
| AU2023307594A1 (en) | 2022-07-15 | 2024-11-28 | Chong Kun Dang Pharmaceutical Corp. | 1,3,4-oxadiazole triazole compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same |
| KR20240035172A (ko) | 2022-09-08 | 2024-03-15 | 주식회사 종근당 | 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이의 용도 |
| TW202426439A (zh) | 2022-10-14 | 2024-07-01 | 韓商鐘根堂股份有限公司 | 作為組蛋白去乙醯酶6抑制劑之磺醯亞胺化合物以及含彼之醫藥組合物 |
| WO2024180464A1 (en) | 2023-02-28 | 2024-09-06 | Chong Kun Dang Pharmaceutical Corp. | Oxadiazole derivative compounds, and the pharmaceutical composition comprising the same |
Family Cites Families (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5304121A (en) | 1990-12-28 | 1994-04-19 | Boston Scientific Corporation | Drug delivery system making use of a hydrogel polymer coating |
| US5716981A (en) | 1993-07-19 | 1998-02-10 | Angiogenesis Technologies, Inc. | Anti-angiogenic compositions and methods of use |
| US6231600B1 (en) | 1995-02-22 | 2001-05-15 | Scimed Life Systems, Inc. | Stents with hybrid coating for medical devices |
| US6099562A (en) | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
| US5837313A (en) | 1995-04-19 | 1998-11-17 | Schneider (Usa) Inc | Drug release stent coating process |
| US6777217B1 (en) | 1996-03-26 | 2004-08-17 | President And Fellows Of Harvard College | Histone deacetylases, and uses related thereto |
| ZA9710342B (en) | 1996-11-25 | 1998-06-10 | Alza Corp | Directional drug delivery stent and method of use. |
| US6273913B1 (en) | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
| US5891507A (en) | 1997-07-28 | 1999-04-06 | Iowa-India Investments Company Limited | Process for coating a surface of a metallic stent |
| US6153252A (en) | 1998-06-30 | 2000-11-28 | Ethicon, Inc. | Process for coating stents |
| US6248127B1 (en) | 1998-08-21 | 2001-06-19 | Medtronic Ave, Inc. | Thromboresistant coated medical device |
| US6258121B1 (en) | 1999-07-02 | 2001-07-10 | Scimed Life Systems, Inc. | Stent coating |
| US6203551B1 (en) | 1999-10-04 | 2001-03-20 | Advanced Cardiovascular Systems, Inc. | Chamber for applying therapeutic substances to an implant device |
| US6251136B1 (en) | 1999-12-08 | 2001-06-26 | Advanced Cardiovascular Systems, Inc. | Method of layering a three-coated stent using pharmacological and polymeric agents |
| US20030129724A1 (en) | 2000-03-03 | 2003-07-10 | Grozinger Christina M. | Class II human histone deacetylases, and uses related thereto |
| AU2001248701A1 (en) * | 2000-03-24 | 2001-10-03 | Methylgene, Inc. | Inhibitors of histone deacetylase |
| JPWO2002074298A1 (ja) * | 2001-03-21 | 2004-07-08 | 小野薬品工業株式会社 | Ｉｌ−６産生阻害剤 |
| US7244853B2 (en) | 2001-05-09 | 2007-07-17 | President And Fellows Of Harvard College | Dioxanes and uses thereof |
| CN1582277A (zh) | 2001-11-01 | 2005-02-16 | 詹森药业有限公司 | 用作糖原合酶激酶3β抑制剂的酰胺衍生物 |
| US6517889B1 (en) | 2001-11-26 | 2003-02-11 | Swaminathan Jayaraman | Process for coating a surface of a stent |
| US7154002B1 (en) * | 2002-10-08 | 2006-12-26 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| KR20050122210A (ko) * | 2003-03-17 | 2005-12-28 | 다케다 샌디에고, 인코포레이티드 | 히스톤 탈아세틸화 효소 억제제 |
| EP1644323B1 (en) | 2003-07-07 | 2015-03-18 | Georgetown University | Histone deacetylase inhibitors and methods of use thereof |
| EP1745022B1 (en) * | 2004-04-05 | 2014-08-13 | Aton Pharma, Inc. | Histone deacetylase inhibitor prodrugs |
| US8999289B2 (en) | 2005-03-22 | 2015-04-07 | President And Fellows Of Harvard College | Treatment of protein degradation disorders |
| EP1940805A4 (en) * | 2005-08-26 | 2009-11-11 | Methylgene Inc | BENZODIAZEPIN AND BENZOPIPERAZINANALOGA AS INHIBITORS OF HISTONDEACETYLASE |
| US8222423B2 (en) * | 2006-02-14 | 2012-07-17 | Dana-Farber Cancer Institute, Inc. | Bifunctional histone deacetylase inhibitors |
| AU2007248656B2 (en) | 2006-05-03 | 2013-04-04 | Dana-Farber Cancer Institute, Inc. | Histone deacetylase and tubulin deacetylase inhibitors |
| WO2007144341A1 (en) * | 2006-06-12 | 2007-12-21 | Vrije Universiteit Brussel | Differentiation of rat liver epithelial cells into hepatocyte-like cells |
| ES2288802B1 (es) * | 2006-07-07 | 2008-12-16 | Universidad De Granada | Nuevos derivados de ftalimida como inhibidores de las histonas desacetilasas. |
| CA2662580C (en) * | 2006-09-11 | 2013-05-21 | Curis, Inc. | Tyrosine kinase inhibitors containing a zinc binding moiety |
| US8119616B2 (en) * | 2007-09-10 | 2012-02-21 | Curis, Inc. | Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety |
| WO2009104696A1 (ja) * | 2008-02-19 | 2009-08-27 | 株式会社アーネストメディスン | 身体機能の回復に有用な経口又は経腸組成物 |
| US8440716B2 (en) | 2008-07-23 | 2013-05-14 | President And Fellows Of Harvard College | Deacetylase inhibitors and uses thereof |
| US8716326B2 (en) * | 2009-05-15 | 2014-05-06 | Korea Research Institute Of Chemical Technology | Isoindolinone derivatives, preparation method thereof and a pharmaceutical composition comprising same |
| US8716344B2 (en) | 2009-08-11 | 2014-05-06 | President And Fellows Of Harvard College | Class- and isoform-specific HDAC inhibitors and uses thereof |
| US20130040998A1 (en) | 2010-01-08 | 2013-02-14 | Dana-Farber Cancer Institute, Inc. | Fluorinated hdac inhibitors and uses thereof |
| NZ601655A (en) * | 2010-01-22 | 2014-10-31 | Acetylon Pharmaceuticals Inc | Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof |
| EP2571352A4 (en) | 2010-05-21 | 2014-09-17 | Sloan Kettering Inst Cancer | SELECTIVE HDAC HEMMER |
| WO2012018499A2 (en) | 2010-08-05 | 2012-02-09 | Acetylon Pharmaceuticals | Specific regulation of cytokine levels by hdac6 inhibitors |
| PL2640709T3 (pl) | 2010-11-16 | 2016-10-31 | Związki pirymidynohydroksyamidowe jako inhibitory deacetylazy białkowej oraz sposoby ich stosowania” | |
| JP6169076B2 (ja) | 2011-07-20 | 2017-07-26 | ザ ジェネラル ホスピタル コーポレイション | 骨疾患の処置のためのヒストン脱アセチル化酵素６選択的阻害剤 |
| EP2839037B1 (en) * | 2012-04-19 | 2018-12-26 | Acetylon Pharmaceuticals, Inc. | Biomarkers to identify patients that will respond to treatment and treating such patients |
| US9145412B2 (en) | 2012-11-02 | 2015-09-29 | Acetylon Pharmaceuticals, Inc. | Selective HDAC1 and HDAC2 inhibitors |
| WO2014121062A1 (en) | 2013-02-01 | 2014-08-07 | Acetylon Pharmaceuticals, Inc. | Selective hdac3 inhibitors |
| US9139583B2 (en) | 2013-02-01 | 2015-09-22 | Acetylon Pharmaceuticals, Inc. | Selective HDAC3 inhibitors |
| EP3004141A4 (en) | 2013-06-03 | 2017-05-31 | Acetylon Pharmaceuticals, Inc. | Histone deacetylase ( hdac) biomarkers in multiple myeloma |
| WO2015054099A1 (en) * | 2013-10-08 | 2015-04-16 | Acetylon Pharmaceuticals, Inc. | Combinations of histone deacetylase inhibitors and either her2 inhibitors or pi3k inhibitors |
| JP2016536354A (ja) | 2013-10-10 | 2016-11-24 | アセチロン ファーマシューティカルズ インコーポレイテッドＡｃｅｔｙｌｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | 非ホジキンリンパ腫を治療するための、ｈｄａｃ阻害剤単独またはｂｔｋ阻害剤との組み合わせ |
| ES2862126T3 (es) | 2013-10-10 | 2021-10-07 | Acetylon Pharmaceuticals Inc | Compuestos de pirimidín-hidroxiamida como inhibidores de histona desacetilasa |
| US20150105383A1 (en) | 2013-10-10 | 2015-04-16 | Acetylon Pharmaceuticals, Inc. | HDAC Inhibitors, Alone Or In Combination With PI3K Inhibitors, For Treating Non-Hodgkin's Lymphoma |
| KR20160060143A (ko) | 2013-10-11 | 2016-05-27 | 에이스틸론 파마수티컬스 인코포레이티드 | 히스톤 디아세틸라아제 억제제와 면역조절성 약물의 조합물 |
| ES2806258T3 (es) | 2013-12-03 | 2021-02-17 | Acetylon Pharmaceuticals Inc | Combinaciones de inhibidores de histona desacetilasa y fármacos inmunomoduladores |
| SG11201700094TA (en) * | 2014-07-07 | 2017-02-27 | Acetylon Pharmaceuticals Inc | Treatment of leukemia with histone deacetylase inhibitors |
| CN107922352B (zh) * | 2015-06-08 | 2021-08-06 | 埃斯泰隆制药公司 | 制备蛋白质脱乙酰酶抑制剂的方法 |
| US10040769B2 (en) * | 2015-10-27 | 2018-08-07 | Regenacy Pharmaceuticals, Llc | HDAC inhibitors for the treatment of diabetic peripheral neuropathy |
| WO2017143237A1 (en) * | 2016-02-17 | 2017-08-24 | Acetylon Pharmaceuticals, Inc. | Increasing expression of interferon regulated genes with combinatons of histone deacetylase inhibitors and immunomodulatory drugs |
| US11298354B2 (en) * | 2016-06-09 | 2022-04-12 | Dana-Farber Cancer Institute, Inc. | Methods of use and pharmaceutical combinations of HDAC inhibitors with BET inhibitors |
| ES2929032T3 (es) * | 2016-08-08 | 2022-11-24 | Acetylon Pharmaceuticals Inc | Combinaciones farmacéuticas de inhibidores de histona desacetilasa 6 y anticuerpos inhibidores de CD20 y usos de los mismos |
| JP7282674B2 (ja) * | 2016-10-28 | 2023-05-29 | アセチロン ファーマシューティカルズ インコーポレイテッド | ヒストン脱アセチル化酵素阻害剤及びオーロラキナーゼ阻害剤を含む医薬品組み合わせならびにその使用方法 |
| EP3544612A4 (en) * | 2016-11-23 | 2020-05-13 | Acetylon Pharmaceuticals, Inc. | PHARMACEUTICAL COMBINATIONS COMPRISING A HISTONE DEACETYLASE INHIBITOR AND A CD38 INHIBITOR AND METHODS OF USING THE SAME |
-
2011
- 2011-01-21 NZ NZ601655A patent/NZ601655A/en unknown
- 2011-01-21 PL PL11735212T patent/PL2526093T3/pl unknown
- 2011-01-21 US US13/010,974 patent/US8394810B2/en active Active
- 2011-01-21 SG SG10201500444TA patent/SG10201500444TA/en unknown
- 2011-01-21 PH PH1/2012/501492A patent/PH12012501492B1/en unknown
- 2011-01-21 HR HRP20161367TT patent/HRP20161367T1/hr unknown
- 2011-01-21 EA EA201290677A patent/EA026514B1/ru unknown
- 2011-01-21 LT LTEP11735212.0T patent/LT2526093T/lt unknown
- 2011-01-21 SI SI201130938A patent/SI2526093T1/sl unknown
- 2011-01-21 EP EP16158086.5A patent/EP3091004B1/en active Active
- 2011-01-21 CA CA2787756A patent/CA2787756C/en active Active
- 2011-01-21 CN CN201610108094.3A patent/CN105753739A/zh active Pending
- 2011-01-21 SG SG2012053930A patent/SG182646A1/en unknown
- 2011-01-21 RS RS20160849A patent/RS55227B1/sr unknown
- 2011-01-21 ES ES11735212.0T patent/ES2592278T3/es active Active
- 2011-01-21 TW TW100102235A patent/TWI511732B/zh active
- 2011-01-21 CN CN201180015409.5A patent/CN102933558B/zh active Active
- 2011-01-21 WO PCT/US2011/021982 patent/WO2011091213A2/en not_active Ceased
- 2011-01-21 DK DK11735212.0T patent/DK2526093T3/en active
- 2011-01-21 BR BR112012018246-3A patent/BR112012018246B1/pt active IP Right Grant
- 2011-01-21 EP EP11735212.0A patent/EP2526093B1/en active Active
- 2011-01-21 JP JP2012550137A patent/JP5940984B2/ja not_active Expired - Fee Related
- 2011-01-21 KR KR1020127021898A patent/KR101808874B1/ko active Active
- 2011-01-21 CN CN201610108022.9A patent/CN105727298A/zh active Pending
- 2011-01-21 TW TW104134007A patent/TWI600638B/zh not_active IP Right Cessation
- 2011-01-21 TW TW106121994A patent/TW201735926A/zh unknown
- 2011-01-21 PT PT117352120T patent/PT2526093T/pt unknown
- 2011-01-21 MX MX2012008553A patent/MX2012008553A/es active IP Right Grant
- 2011-01-21 HU HUE11735212A patent/HUE030679T2/en unknown
- 2011-12-02 US US13/310,168 patent/US8148526B1/en active Active
-
2012
- 2012-04-02 US US13/437,672 patent/US8609678B2/en not_active Expired - Fee Related
- 2012-07-20 CL CL2012002026A patent/CL2012002026A1/es unknown
- 2012-08-13 ZA ZA2012/06063A patent/ZA201206063B/en unknown
-
2013
- 2013-11-11 US US14/076,596 patent/US20140142117A1/en not_active Abandoned
-
2014
- 2014-10-22 US US14/521,189 patent/US20150045380A1/en not_active Abandoned
-
2016
- 2016-05-19 JP JP2016100346A patent/JP2016153425A/ja active Pending
- 2016-08-09 AU AU2016213729A patent/AU2016213729A1/en not_active Abandoned
- 2016-09-12 US US15/262,899 patent/US20160375021A1/en not_active Abandoned
- 2016-10-26 CY CY20161101080T patent/CY1118156T1/el unknown
- 2016-10-26 SM SM201600382T patent/SMT201600382B/it unknown
-
2019
- 2019-08-26 US US16/550,763 patent/US11617750B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201591775A1 (ru) | Замещенные ароматические соединения и связанный с ними способ лечения фиброза | |
| EA201391263A1 (ru) | Комбинированные терапии гематологических опухолей | |
| JP2015518055A5 (enExample) | ||
| RU2018106914A (ru) | 1,3,4,-оксадизоламидное производное соединение в качестве ингибитора гистондеацетилазы 6 и содержащая его фармацевтическая композиция | |
| JP2017537940A5 (enExample) | ||
| PH12018500212A1 (en) | 1,3,4-oxadiazole sulfonamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same | |
| JP2016532667A5 (enExample) | ||
| EA201391158A8 (ru) | Диаминиевые соли фенотиазина и их применение | |
| EA201591774A1 (ru) | Замещенные ароматические соединения для лечения легочного фиброза, фиброза печени, фиброза кожи и фиброза сердца | |
| EA201300250A1 (ru) | Оксадиазольные ингибиторы продуцирования лейкотриена | |
| JP2016534134A5 (enExample) | ||
| JP2016503786A5 (enExample) | ||
| EA201391629A1 (ru) | Ингибиторы цсж-1r для лечения опухолей головного мозга | |
| JP2016531113A5 (enExample) | ||
| EA201690094A1 (ru) | Ингибиторы syk | |
| EA201001159A1 (ru) | Конденсированные гетероциклические производные и их применение | |
| AR101177A1 (es) | Inhibidores de la syk | |
| EA201290677A1 (ru) | Соединения обратного амида в качестве ингибиторов протеиндеацетилазы и способы их применения | |
| EA201400358A1 (ru) | Замещенные n-[1-циано-2-(фенил)этил]-2-азабицикло[2.2.1]гептан-3-карбоксамидные ингибиторы катепсина с | |
| RU2013108348A (ru) | Конденсированные гетероарилы и их применение | |
| JP2013506639A5 (enExample) | ||
| RU2010144637A (ru) | Замещенные гамма-лактамы в качестве терапевтических агентов | |
| EA201490552A1 (ru) | Холиновая соль замещенного циклобутендиона, обладающая противовоспалительной способностью | |
| JP2013533253A5 (enExample) | ||
| RU2019141734A (ru) | Терапевтические соединения и композиции и способы их применения |